Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109269263 | 10926926 | 3 | F | 2014 | 20160706 | 20150318 | 20160906 | PER | US-ASTRAZENECA-2014SE73536 | ASTRAZENECA | 60.00 | YR | M | Y | 107.00000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109269263 | 10926926 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | AM140007 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 109269263 | 10926926 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 109269263 | 10926926 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 5.0UG UNKNOWN | Y | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||
| 109269263 | 10926926 | 4 | SS | BYDUREON | EXENATIDE | 1 | Unknown | 0 | 2 | MG | /wk | ||||||||
| 109269263 | 10926926 | 5 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 109269263 | 10926926 | 6 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | 1 | DF | QD | |||||||||
| 109269263 | 10926926 | 7 | C | MAGNESIUM CITRATE. | MAGNESIUM CITRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109269263 | 10926926 | 1 | Type 2 diabetes mellitus |
| 109269263 | 10926926 | 2 | Type 2 diabetes mellitus |
| 109269263 | 10926926 | 3 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109269263 | 10926926 | Blood cholesterol decreased | |
| 109269263 | 10926926 | Blood glucose decreased | |
| 109269263 | 10926926 | Blood glucose increased | |
| 109269263 | 10926926 | Constipation | |
| 109269263 | 10926926 | Decreased appetite | |
| 109269263 | 10926926 | Drug ineffective | |
| 109269263 | 10926926 | Gastrointestinal pain | |
| 109269263 | 10926926 | Hyperhidrosis | |
| 109269263 | 10926926 | Hypoglycaemia | |
| 109269263 | 10926926 | Inappropriate schedule of drug administration | |
| 109269263 | 10926926 | Nausea | |
| 109269263 | 10926926 | Tremor | |
| 109269263 | 10926926 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109269263 | 10926926 | 1 | 2006 | 2010 | 0 | |
| 109269263 | 10926926 | 2 | 201310 | 0 | ||
| 109269263 | 10926926 | 3 | 201311 | 2014 | 0 | |
| 109269263 | 10926926 | 4 | 20150411 | 0 |